Plaats | datum Choices in health decision-making Coverage in the Netherlands Bert Boer, MD, PhD Health Care Insurance Board (CVZ) Rotterdam, November 2010.

Slides:



Advertisements
Similar presentations
Accra, Ghana October 19-23, Extending Health Insurance: How to Make It Work DESIGN ELEMENT 4: BENEFITS PACKAGES AND COST CONTAINMENT 2/9/2014October.
Advertisements

MOVING TOWARDS A HEALTHIER HARFORD KATHERINE RICHARDSON, MD An Analysis of Obesity Prevention Interventions for Harford County, Maryland.
Barbara M. Altman Emmanuelle Cambois Jean-Marie Robine Extended Questions Sets: Purpose, Characteristics and Topic Areas Fifth Washington group meeting.
World Health Organization
L1:Apply the concepts of health and wellness to identify health behaviours and factors influencing choice and change in health using an holistic approach.
Health Technology Assessment and evidence-informed decision making
SMC Evaluation Programme. Overview Context Evaluation Programme –Stakeholders –SMC advice Conclusions.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Health Technology as Policy: Challenges for Technology Assessment Mita Giacomini, Ph.D. Centre for Health Economics & Policy Analysis Department of Clinical.
Assessment and Appraisal: Fundamental Aspects of Health Care Kent Woods Director, NHS Health Technology Assessment Programme.
Title slide PIPELINE QRA SEMINAR. PIPELINE RISK ASSESSMENT INTRODUCTION TO GENERAL RISK MANAGEMENT 2.
HTA & Medical Devices: An International Perspective Christina Farup, MD, MS | April 2015.
Writing level 3 essays An initial guide. Key principles The key principles of essay writing still apply: Understanding the topic Plan your response Structure.
The National Institute for Clinical Excellence in the UK – Experience and Impact Mark Sculpher Professor of Health Economics Centre for Health Economics.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Using hotlines to improve women’s access to information in legally restricted settings Bangkok, March 9-11, 2012 Challenges for documenting hotlines’s.
Prevention of teenage pregnancies, best practice from the Netherlands Ineke van der Vlugt Programme coordinator Rutgers Nisso Groep.
Erasmus University Rotterdam The Dutch Reforms, Gresham College, London, 27jan11 1 Choice of providers and mutual healthcare purchasers: the Dutch reforms.
Systematic Approaches to Literature Reviewing. The Literature Review ? “Literature reviews …… introduce a topic, summarise the main issues and provide.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
1 PRESENTATION TO THE PORTFOLIO COMMITTEE ON PUBLIC SERVICE AND ADMINISTRATION 1 June 2005 INVESTIGATION INTO THE RE- EMPLOYMENT OF PERSONS RETIRED DUE.
Introduction to MAST Kristian Kidholm Odense University Hospital, Denmark.
UNEP Training Resource ManualTopic 1 Slide 1 Aims and objectives of EIA F modify and improve design F ensure efficient resource use F enhance social aspects.
Propositions A proposition is the declarative statement that an advocate intends to support in the argument. Some propositions are stated formally, some.
Spreker | Plaats | datum Getting the relevant answers… KNAW - Science for affordable Health Care april 17th, 2013 Bert Boer Health Care Insurance Board.
HTA and Health Care Decisions in Slovakia. PharmDr. Martin Višňanský, MBA, PhD. President - ISPOR Local Chapter, Slovakia Slovak Agency for Health Technology.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Potential Roles for Health Technology Assessment Agencies: Opportunities and Challenges for an Effective Health Technology Assessment Practice at the Meso.
Supporting tough decisions: linking Health technology assessment (HTA) and national priority setting in Norway Ånen Ringard 1, Berit Mørland 1,2 1 Secretariat.
RISK MANAGEMENT The process of weighing policy alternatives in the light of the results of risk assessment and, if required, selecting and implementing.
Results The final report was presented to NICE and published by NICE and WHO. See
Housing association objectives need to be under one roof Jan Veuger BSc MRE PhD FRICS NoorderRuimte, Centre of Research and Innovation for Build Environment,
1 Internal Audit. 2 Definition Is an independent activity established by management to examine and evaluate the organization’s risk management processes.
Evidence, HTA and Comparative Effectiveness in the U.S. Presentation at AMCP March 28, 2007 Peter J. Neumann Tufts-New England Medical Center.
Keller and Heckman LLP Market Access and Trade Barriers and Practices: The Role of the Precautionary Principle and Other Non-Scientific Factors in Regulating.
EUnetHTA Joint Action 2010–2012 | EUnetHTA Joint action Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.
Current Challenges and Future Developments in HTA in the UK Frances Macdonald, 23 rd September 2008 (A personal, Industry View)
USING ECONOMIC EVIDENCE AND STAKEHOLDER'S PARTICIPATION IN DECISION MAKING ON BENEFIT PACKAGE OF UNIVERSAL HEALTH COVERAGE SCHEME IN THAILAND RESULTS:
Themes Emerging from Country and Related Presentations Notes from session 1545 – 1730 Thursday 17 February 2011 Albert Weale.
PHARMACOECONOMICS Dr. Mohammad Aljawadi, PharmD PhD Department of Clinical Pharmacy King Saud University Aug, 2015 PHCL 431.
Comparative Process Analysis Who Gets What, When, Where, How & Why?
Insuring America’s Health: Principles and Recommendations An Institute of Medicine Report Presented By Shoshanna Sofaer, Dr.P.H. School of Public Affairs,
source: [ ]
Becoming ADEPT 2 October 2003 Janette Boynton Senior Health Information Scientist.
Introduction to Public Policy. Outline What is public policy? Why study it? Contexts of public policy Reasons for government intervention Role of policy.
PLANNING CYCLE An Overview. CONTENT Expected achievements Expected achievements Why IWRM Planning? Why IWRM Planning? Why a strategic approach? Why a.
HEALTH FINANCING MOH - HPG JAHR UPDATE ON POLICIES Eleventh Party Congress -Increase state investment while simultaneously mobilizing social mobilization.
Peer Evaluation of the Norwegian Board of Health Supervision (Statens helsetilsyn) First of its kind. Performed by EPSO Peer Evaluation Team Norway (July.
Workshop 18 th May 2010, Brussels Applying the Value+ model on patient involvement in HTA processes.
Marketing Research An introduction. Marketing Research Marketing research is a combination of two words i.e marketing and research Marketing is essentially.
DrugEpi 5-4 Policy Question: D.A.R.E. Module 5 Overview Context Content Area: Policy Decisions about Drug Use/Abuse Issues Essential Question (Generic):
Knowledge Translation for Improving Health Masoud Solaymani-Dodaran MD MPH PhD FFPH CCT.
Citywide Drugs Crisis Campaign 20 years experience of Community Involvement – Key Lessons for the next National Drugs Strategy 12 TH NOVEMBER 2015.
John N. Lavis, MD, PhD Professor and Canada Research Chair in Knowledge Transfer and Exchange McMaster University Program in Policy Decision-Making McMaster.
How to weight cost effectiveness in appraisal NVTAG / CVZ course: The appraisal process, work in progress 22th of April 2009 Jan van Busschbach.
EVALUATION OF THE SEE SARMa Project. Content Project management structure Internal evaluation External evaluation Evaluation report.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
Department of Health Service Research Head: Prof. Dr. Ansgar Gerhardus Interactive session: Presentation of the INTEGRATE-HTA Model and short discussion.
John N. Lavis, MD, PhD Professor and Director, McMaster Health Forum McMaster University Program in Policy Decision-Making McMaster University 7 June 2012.
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
Integrating Qualitative Research Into Health Technology Assessment in Canada The CADTH Experience Laura Weeks, PhD Scientific Advisor Kristen.
Making Every Contact Count (MECC) and Optimising Outcomes Dr Siân Griffiths Consultant in Public Health Medicine.
Rosemarie Bernabe, PhD Julius Center for Health Sciences and Primary Care Patient representatives’ contributions to the benefit-risk assessment tasks of.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Genomics in Public Health.
Developing a guideline
TECHNOLOGY ASSESSMENT
Professor of Health Economics
Realizing effective health technology assessment for the SA healthcare environment Praneet Valodia The BHF Southern African Conference July’07.
Presentation transcript:

Plaats | datum Choices in health decision-making Coverage in the Netherlands Bert Boer, MD, PhD Health Care Insurance Board (CVZ) Rotterdam, November 2010

1 Key Message Times are changing for HTA  The context (policy, politics) of HTA is not (anymore?) as was assumed  HTA as being intrinsic receiver oriented, has to be responsive to the apparently changing contextual values

2 Choices in coverage 1.Coverage in the Netherlands: system, principles 2.Recent experiences in managing the package of benefits 3.Four principles for coverage: applicable, relevant? 4.Assessment, societal appraisal, political decisions 5.Conclusions 6.During drinks: HTA, how to proceed?

3 1.Coverage in the Netherlands (system, principles:)  Mandatory insurance for all  Mandatory acceptance for insurance companies  Public definition of the package of benefits

4 Mgt. of the package of benefits (tasks of CVZ:)  Explaining what’s in it and what’s not, and why  Statements on insurance status (application of general criteria to specific technologies)  Advice on inclusions / exclusions  Advice in disputes  Advice on coverage system: criteria, structure  Monitoring utilization (spec. topics, i.e. drugs)

5 Mgt. of the package of benefits: four basic principles  Necessity  of health care (severity, burden if illness)  of health care coverage (predictability, affordability, …)  Effectiveness  Cost-effectiveness  Feasibility

6 2. Recent experiences Introduction of the societal appraisal committee (ACP) implied introduction of appraisal Appraisal or assessment of the four principles?  Necessity  Effectiveness  Cost-effectiveness  Feasibility Assessment: 1a, 2, 3, and domain (a preceding general consideration) Appraisal: 1b, 4

7 2. Recent experiences (#2) Shift in the traditional sequence “assessment/appraisal” Examples:  Scoping of relevant aspects for assessment  Choice for relevant effects to be assessed depends on social values Repeated assessment (and - decisions) are increasingly needed Lack of evidence about effectiveness stops the game

8 What was the decisive criterion? Review of the last 10 CVZ-advices on in- or exclusion of services Which of the four basic principles appeared to be decisive?

9 AdviceKey criterion Combined life-style intervention effectiveness Contraceptiondomain Devices for walking assistance necessity Dentistry for age 18-22necessity IVFdomain Acetylcysteineffectiveness Oxycodineffectiveness Smoking cessationnecessity Dietary productsnecessity TNF-alpha blockerseffectiveness

10 3. Conclusions about principles 1.Necessity has to be split 2.Although we strive for integral application of the principles, lack of (proof of) effectiveness is the end of the story (no other aspects assessed) 3.Cost-effectiveness and feasibility appeared to be non-decisive 4.In two cases we needed the preceding question about the limits of the health domain  Former examples dyslexia; cosmetic surgery  Legal basis for this question in the Health Insurance Act

11 4. Assessment, Appraisal, CVZ advice, political decisions In “95 %” political decisions follow the CVZ advice Delicate issues, to be evaluated:  Between advisory committee (ACP) and CVZ-board: Smoking cessation, contraception  Between CVZ and MoH: contraception  Within “politics” (MoH1/MoH2, MoH/parliament): walking assisting devices

12 The role of politics CVZ always acknowledged the possibility of different weighing of arguments by politicians But: We attempt to prevent “new” arguments in the political debate What lessons to be learned from recent politics? Should we change the principles? Only if politics appears to systematically use other principles

13 5. Conclusions The classical HTA-sequence “research - decision” doesn’t fit anymore Cost-effectiveness is not very often decisive We should reconsider the role (sequence, weight) of the four assessment criteria and the relationship with appraisal and decision making We need “methodology” for the societal appraisal

14 Drinks… HTA is multidisciplinary research for policy decisions If so, then:  HTA has to develop from (only) health economics into the review of all relevant facts  Assessment doesn’t always precede appraisal; in many cases it’s the other way around  HTA has to be enriched by criteria and methods for societal appraisal

Plaats | datum Choices in health decision-making Coverage in the Netherlands Bert Boer, MD, PhD Health Care Insurance Board (CVZ) Rotterdam, November 2010